Press Releases

Sandoz, a Novartis division and the global leader in biosimilars, announced a global resolution of all intellectual property (IP) related litigation with AbbVie concerning the proposed Sandoz biosimilar Hyrimoz® (adalimumab) for reference medicine Humira®** (adalimumab).

Almac Diagnostic Services, a global stratified medicine company specialising in biomarker driven clinical trials, has made a significant investment in a new Illumina NovaSeq 6000 sequencer which will benefit Biopharma clients’ biomarker discovery and clinical trial projects.

Roche announced that the US FDA has approved Hemlibra® (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with haemophilia A without factor VIII inhibitors.

United Cargo announced it will enhance its TempControl service and expand the options it offers shippers of pharmaceuticals and other life science products by approving the new CSafe RAP active container.

Aptar Pharma, a leading provider of innovative drug delivery systems, in combination with Schott Glass and EMA Pharmaceuticals, has announced that it will launch Aptar Pharma QuickStart™ for injectable drug development at CPhI Worldwide 2018, in Madrid, Spain, October 9th.

apceth Biopharma GmbH, a leading company for the development and manufacturing of cell and gene therapeutics, congratulates its partner bluebird bio on the acceptance and validation of its market authorization application by the European Medicines Agency (EMA).

MetP® Pharma, focusing on the nasal delivery of drugs to the systemic circulation and especially to the brain, presents its Nascum®-Plus nasal gel.

Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, announced that the EMA has granted Priority Medicines (PRIME) designation to OTL-300, an investigational autologous ex vivo lentiviral gene therapy for the treatment of transfusion-dependent beta-thalassemia (TDBT), the most severe form of beta-thalassemia.

Piramal Pharma Solutions (PPS), a global leader in Contract Development and Manufacturing Solutions, announced the launch of its Xcelerate Integrated Solutions™ platform to address a rapidly growing market need.

RayDyLyo® a breakthrough innovation with multiples benefits
RayDyLyo® is an all-plastic capping solution designed to work with all ISO stopper configurations (serum and lyo).

OTTR, the leading provider of solid organ transplant and cellular therapy patient tracking software, is introducing a new module for immune effector cells (IEC) within its CompleteCellular solution.

Aptar Pharma, a leading drug delivery systems provider, continues its commitment to meeting new market trends with the release of an industry first, PureHale, a new portable and ready-to-use drug delivery solution designed for upper respiratory care.

Biotage , a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of Biotage® Selekt, a new flash purification system and the new Biotage® Sfär family of flash purification columns.

Liver4Life is a project of Wyss Zurich, a joint research and development center of the ETH Zurich and the University of Zurich in the fields of Regenerative Medicine and Robotics.

Protagen AG, the National Center for Tumor Diseases (NCT) and NEC Laboratories Europe GmbH have announced a collaboration to improve the in silico prediction of immunotherapy response in malignant melanoma.

CPhI Worldwide, organised by UBM (part of Informa PLC), announces the finalists of the eagerly anticipated 2018 CPhI Pharma Awards.

SYMBIOSIS Pharmaceutical Services, a fast-growing specialist sterile manufacturing CDMO, has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK.

Videojet Technologies has launched a brand new application - the Videojet Pharma Line App – to provide instant information and guidance for customers looking to code or mark onto pharmaceutical and medical device packaging.

CPhI Worldwide the world’s largest pharma event – taking place in Madrid (9-11, October 2018) and organized by UBM (part of Informa plc) – has released the second part of its annual report, which evaluates the effects of regulatory divergence, trade agreements and IP rights over the next 5-years.

Neurimmune announced the achievement of a key preclinical milestone in the ongoing collaboration with Ono Pharmaceutical Co., Ltd. In November 2017, the parties entered into a collaboration focused on the development of human-derived antibodies against a novel therapeutic target for neurodegenerative diseases.

Smart Home and Horticultural Lighting Under Spotlight

Antares Vision, the global leader in inspection systems, track and trace and smart data management headquartered in Italy, is proud to announce the signing of a new joint venture with the Indian company Jay Instruments And Systems Private Limited to establish direct operations in the Indian market.

Proteins are the building blocks of life. They form the structure of cells, regulate cellular activity and carry out the biochemical processes that underpin function in every living organism.

Aptar Pharma, a leading drug delivery systems provider, is pleased to showcase its commitment to meeting new market trends at CPhI Worldwide this year.

With 9,641 visitors and 261exhibitors, analytica Anacon India, India Lab Expo and PHARMA Pro&Pack Expo has chalked up the best-ever result in its decade-old history and surpassed all expectations.

The two synergistic trade exhibitions for the medical, healthcare and MedTech sectors, MEDICAL FAIR ASIA and MEDICAL MANUFACTURING ASIA 2018 closed to resounding success on 31st August.

Clinerion and Semicrol announce a collaboration which will integrate the functionality of Clinerion’s Patient Network Explorer with Semicrol’s Fundanet CTMS.

Zenith Technologies, a world leader in delivering GMP manufacturing software solutions to the life sciences industry, has launched and rolled out a global 24/7 manufacturing IT support service specially designed to meet the needs of the Life Science industry.

WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of Fruquintinib capsules (Elunate®) for metastatic colorectal cancer from the National Medical Products Administration of China ("NMPA") – formerly the China FDA.

Sartorius Stedim Biotech , a leading international supplier for the biopharmaceutical industry, and Repligen Corporation , a global life sciences company focused on bioprocessing technologies, have entered into a collaboration agreement to integrate Repligen’s XCell™.

Clinerion, a real-world data solutions firm focusing on improving efficiency in clinical trials across geographies, and Patient iP, a health data and analytics company providing patient data insights to accelerate and transform clinical research within the United States, are partnering to improve clinical trial design, site selection and patient enrollment.

MEDICAL FAIR ASIA 2018 and MEDICAL MANUFACTURING ASIA 2018 was opened by Dr Koh Poh Koon, Senior Minister of State for Trade and Industry, at the Marina Bay Sands, Singapore.

CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, launches a self-service capability and a customer enablement program to empower CROs and Sponsors to manage all aspects of electronic informed consent using a licensed, cloud-based version of the industry’s first electronic informed consent platform with fully embedded design tool.

At POWTECH India 2018, in Mumbai, Germany based Glatt Ingenieurtechnik and its Indian subsidiary, Glatt India, will show case cutting-edge fluidized bed and spouted bed technologies that have been specifically designed to spray-granulate, dry or encapsulate fluids, and spray-agglomerate and functionalize powders for a broad range of innovative applications.

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound contract with a leading multi-billion dollar global ecommerce provider of reagents and tools to the research and clinical community.

The Hygeia Group, comprising three hospitals in Athens, Greece, joins Clinerion’s hospital network, and expands Clinerion’s Patient Network Explorer footprint in Europe.

Under the new management of Messe Muenchen India, the leading exhibition on pharma processing & packaging machineries – PHARMA Pro&Pack 2018 is expected to feature over 100 exhibitors and attract more than 3,000 quality trade visitors from 6-8 September 2018 at HITEX Exhibition Centre in Hyderabad.

More than 300 companies will be exhibiting at India’s leading trade fair for laboratory technology, analysis, biotechnology and diagnostics industry displaying the best of the technologies.

Lannett Company, Inc. announced that it has entered into an exclusive perpetual licensing agreement with Andor Pharmaceuticals, LLC for Methylphenidate Hydrochloride Extended Release (ER) tablets USP (CII) in 18 mg, 27 mg, 36 mg and 54 mg strengths. 

Novartis and Albumedix Ltd. have entered into an agreement to evaluate the development of several first-in-class therapeutics using Albumedix’s Veltis® technology platform and associated technologies.

Titan Pharmaceuticals, Inc. announced that it has entered into an amendment of the previously announced definitive asset purchase, supply and support agreement with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A. through which Molteni acquired the European intellectual property related to Probuphine®.

A new series of compact refrigerators has been specifically developed to address the need of clinical laboratories and patient care facilities for cold storage equipment that enable secure and energy-efficient storage of vaccines, medicines, lab kits and breast milk, while offering quiet operation and a small footprint.

Ashfield Healthcare Communications, a global micro network of connected agencies, part of UDG Healthcare plc, is set to expand its business further by opening an office in the heart of Manchester, UK.

Chugai Pharmaceutical Co., Ltd. announced that it has decided to expand the business of Chugai Pharmabody Research Pte. Ltd. (hereinafter referred to as “CPR”), its research subsidiary in Singapore.

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain has confirmed Chester Medical Solutions as the first UK-based CDMO to select its EU FMD Express solution.

The Pistoia Alliance has announced that entries for its 2018 President’s Startup Challenge are now open, and will close on Monday, 3rd September 2018.

In December 2017, the new METTLER TOLEDO M_one was installed at a world-renowned National Metrology Institute in Europe. Experts at this preeminent institute expect the highly precise vacuum mass comparator to be instrumental in further research into the establishment of a redefined kilogram.

Axol Bioscience, the human cell culture specialist, provide highly validated primary cells and iPSC-derived cells together with optimised media and growth supplements, launch their Human iPSC-derived Atrial Cardiomyocytes for the discovery and development of novel treatments and advancing our understanding of cardiovascular disease.

Clinerion has signed a Memorandum of Understanding with the P-HIS Development Group of Korea University Medical Center (KUMC) to support the KUMC’s activities in developing a patient data platform in the Republic of Korea, in particular for precision medicine.

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, announced Product Information Manager, a standards-based network application built on TraceLink’s end-to-end information-sharing platform.

CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has entered into a significant enterprise agreement with leading Japanese drug development organization, ONO Pharmaceutical Co., Ltd.

Life Science industry represents an excellence of our country: Italy is one of the leading pharmaceutical producers in the European Union, thanks to investments in innovation of the entire supply chain.

The Advanced Therapies Commercialisation Congress is a collaborative, multi-stakeholder meeting for exchanging views and exploring business approaches for the evolving ATMP segment.

This year, MEDICAL FAIR ASIA will stage its largest edition to date, with over 1,000 exhibitors including 24 country groups, over 10,000 medical and healthcare products, as well as the special zones of - Community Care Pavilion, Start-Up Park and Future 4 Health (FTR4H) Lab & Lounge.

Aarhus University's Interdisciplinary Nanoscience Center (iNANO) and Albumedix Ltd. (‘Albumedix’) have entered into a strategic research collaboration to evaluate the transport properties of albumin for site-selective drug delivery into disease cells to ensure more efficient and safer treatment for patients.

Plasticell, a developer of stem cell technologies and therapies, has announced it is leading a consortium of pioneering gene therapy groups at UCL’s Institute of Child Health (ICH) and Great Ormond Street Hospital (GOSH) to develop advanced technologies for the manufacturing of ex vivo gene therapies.

CASI Pharmaceuticals, Inc , a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in the U.S., China and throughout the world, announces a strategic and long-term manufacturing agreement with Yiling Wanzhou International Pharmaceutical Co., Ltd. for the manufacturing of entecavir and cilostazol.

Powder containment and aseptic transfer valve specialist, ChargePoint Technology has achieved triple-digit growth in key Asian markets and will be exhibiting its sterile and highly potent handling capabilities at Interphex Japan 2018 on stand E1-001.

Processa Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have a high unmet medical need, announced hat the U.S. FDA has granted orphan-drug designation to its leading clinical compound PCS499 for treatment of Necrobiosis Lipoidica (NL).

Aptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the approved delivery device for Bausch+Lomb’sLevofree Multidose in France.

Global contract manufacturing organisation, Orion Contract Manufacturing, has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital®.

On 25 June 2018, Lonza, in collaboration with Kirkstall Ltd., a biotechnology company based in Rotherham (UK), is hosting a free 60-minute webinar on the development of more physiologically relevant 3D lung-immune cell models for enhanced disease modeling.

STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, announces that its partner, Ascletis has received approval from China Food and Drug Administration (CFDA) of its Category 1 new drug, Ganovo® (also known as Danoprevir or ASC08), to treat viral hepatitis C.

Sustainable engineering is more than a buzzword in today’s industry 4.0. Zero leakage, the reduction of fugitive emissions and environmentally safe manufacturing have become top priorities for both end users and producers.

Powder containment and aseptic transfer valve specialist ChargePoint Technology continues its growth strategy within the German, Austrian, and Swiss regions with its recent appointment of a new regional business development manager, Patrick Werner.

Highly regulated manufacturing operations must control access to devices, applications and physical spaces to ensure data integrity, compliance and security without compromising productivity. Nymi is bringing a new innovative authentication solution to these operations with the Nymi Enterprise Edition.

The Wasdell Group (Wasdell), a leading outsourcing partner to companies within the pharmaceutical, medical device and clinical trials industries, is investing £500k in a new laboratory at its Newcastle site.

Progressive Care Inc , a personalized healthcare services and technology company, announced that the company has completed the installation of a TCGRx Automated Pouch Packaging System at its Miami-Dade County PharmCo location.

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes.

P-MEC China will be held at the Shanghai New International Expo Center (SNIEC), Shanghai, China, from 20-22 June. The event is seen as an accurate gauge of industry growth potential, and features a large exhibition and several in-depth conferences.

The University Hospital Center (UHC) Zagreb brings 1.3 million patients to Clinerion’s network of hospitals, expanding its global footprint into Croatia.

Aptar Pharma, a leading provider of innovative drug delivery systems, and Propeller Health, a leading digital therapeutics company, announced plans to collaborate on the launch of a comprehensive platform to develop digital medicines for multiple therapeutic areas and diseases.

CRF Health, a leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, announced that the company has been recognized as2018 New Entrant of the Year in Romania’s PIN Awards.

A new report by CPhI forecasts sizable changes ahead for the pharma markets in the Middle East and Africa over the next few years.

Pfizer Inc. announced the United States FDA approved RETACRIT® (epoetin alfa-epbx), a biosimilar to Epogen® and Procrit® (epoetin alfa)1, for all indications of the reference product. RETACRIT is now the first and only biosimilar erythropoiesis-stimulating agent (ESA) to be approved in the U.S.

Recipharm, the contract development and manufacturing organisation (CDMO), has established a dedicated taskforce to manage the potential impact of Brexit on its organisation.

Aptar Pharma, a leading drug delivery systems provider, is pleased to be exhibiting once again at CPhI China 2018, taking place from June 20-22 at the Shanghai New International Exhibition Center, Shanghai, China.

Lonza announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio.

Cleveland Clinic and Brooks Automation. Inc. willlaunch a 21,000-square-foot biorepository in Cleveland’s Fairfax neighborhood to enhance researchers’ study of human tissue samples and advance personalized medicine for an array of conditions – including cancer, heart disease, and epilepsy.

Density of raw materials and finished products affects their quality and lifetime. A properly performed density determination analysis may be crucial to verify material characteristics.

UCB announced that the U.S. FDA has approved a supplemental new drug application (sNDA) for the company’s newest anti-epileptic drug BRIVIACT CV oral formulations indicated as monotherapy and adjunctive therapy in the treatment of partial onset (focal) seizures in patients age four years and older. 

Novartis announced that the US FDA has approved Gilenya® (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis (RMS), making it the first disease-modifying therapy indicated for these patients.

Powder containment and aseptic transfer valve specialist, ChargePoint Technology, has launched a unique Smart monitoring hub to support efficiency and safety within chemical and pharmaceutical manufacturing processes.

CRF Health, the leading provider of patient-centered eSource for the life sciences industry, announced that its electronic Clinical Outcome Assessment (eCOA) solutions have been selected for a significant insomnia trial by a European pharmaceutical company specializing in the discovery and development of small molecules.

STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec, announces that its active pharmaceutical ingredient (API) R&D and manufacturing facility located in Changzhou, China has secured Pre-Approval Inspection (PAI) for two APIs from the U.S. FDA – with no Form 483s issued. This is the first time that WuXi STA’s Changzhou facility has been inspected by the FDA.

Organised by HKTDC and co-organised by the Hong Kong Medical and Healthcare Device Industries Association, the ninth edition of the HKTDC Hong Kong International Medical Devices and Supplies Fair opened today and continues through 9 May at the Hong Kong Convention and Exhibition Centre.

The 8thInternational Trade Exhibition and Conference on Analytical Laboratory Equipment & Technology, Biotechnology & Life Sciences and Chemical & Safety will return again during 12th– 14thSeptember 2018 at EH102-103, BITEC, Thailand. 

On 16 May 2018, Lonza is hosting a free 60-minute webinar on innovative technologies for building advanced human liver culture platforms that better mimic common liver diseases, such as non-alcoholic fatty liver disease, liver fibrosis and hepatitis B viral infection.

Biogen and Neurimmune announced that Biogen has exercised its option to further reduce the previously negotiated royalty rates payable on potential future sales of aducanumab, Biogen’s Phase 3 investigational treatment for early Alzheimer’s disease.

The Asian Pharma IT Summit 2018 is a premium strategic platform for large pharma, biotech, leading research institutes and technology pioneers to explore the real world value and application of the most cutting-edge technology along the R&D pipeline.

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced key organizational changes within its biologics business to further align its organization with customer demand for integrated and comprehensive, end-to-end biologics solutions.

Messe Muenchen India organized a regional edition of analytica Anacon India and India Lab Expo, the market leading trade fairs for laboratory technology, analysis, biotechnology and diagnostics.

It was privilege for the team of World Pharma Today to interact with the officials of Nanning Sugar Industry Co. Ltd. at API China 2018.

Dotmatics Ltd, a leading provider of scientific informatics solutions and services, announced Bioregister 3.0, a major update to the company’s web-based system for registering and managing biological entities used in the development of novel biologic compounds.

Provepharm Life Solutions announces that ArchiMed and Téthys Invest have joined the company’s shareholder base as minority investors.

Codexis, Inc and Porton Pharma Solutions, Ltd announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active pharmaceutical ingredients (API) development and manufacturing business.

The Health Industry Summit (tHIS) 2018 hosted by Reed Sinopharm, opened in Shanghai at the National Exhibition and Convention Center on 11th April 2018. This is the largest gathering of healthcare industry professionals in the world with well over 200,000 attendees from more than 150 countries and regions and over 7,000 exhibitors.

The 6th annual conference will gather the growing freeze drying community, filled with industry thought leaders and principle scientists involved in: manufacturing, material sciences, bio-therapeutics and pharmaceutical engineering.

SMi are delighted to have interviewed our speaker Maxime Gaillot, Senior Device Engineer, Roche, for Injectable Drug Delivery!

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, announced EU FMD Express – a cost-effective, simplified solution designed specifically to address the needs of smaller pharmaceutical companies complying with the EU Falsified Medicines Directive (FMD.)

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok